Skip to main content
Clinical Trials/IRCT20201021049095N1
IRCT20201021049095N1
Recruiting
Phase 3

Comparative assessment of the effect of corticosteroid in three forms of Budesonide nasal spray, Betamethasone nasal drop, and Budesonide nebulizing suspension on sinonasal polyposis recurrence after the FESS

Shahid Beheshti University of Medical Sciences0 sites108 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Shahid Beheshti University of Medical Sciences
Enrollment
108
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • FESS candidates with sinonasal polyposis
  • patients between 18 to 70 years old

Exclusion Criteria

  • Absence of underlying diseases, including CF, Wegener's, Kartagener, sarcoidosis, vasculitis, or rheumatic diseases;
  • Receiving no systemic corticosteroids for up to 4 weeks before surgery;
  • ages below 18 or higher than 70 years olds

Outcomes

Primary Outcomes

Not specified

Similar Trials